65 related articles for article (PubMed ID: 1810398)
1. Anaplastic ependymoma in children--increasing incidence?
Talan-Hranilović J; Lambasa S; Kogler A
Neurol Croat; 1991; 41(1-2):51-5. PubMed ID: 1810398
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic results of eight patients with intracranial ependymomas].
Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
[TBL] [Abstract][Full Text] [Related]
3. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
4. Recurrence in supratentorial anaplastic ependymoma.
Kumar R; Singhal N; Jaiswal SK; Mahapatra AK
Pediatr Neurosurg; 2007; 43(5):364-8. PubMed ID: 17786000
[TBL] [Abstract][Full Text] [Related]
5. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
6. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
7. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.
Fouladi M; Helton K; Dalton J; Gilger E; Gajjar A; Merchant T; Kun L; Newsham I; Burger P; Fuller C
Cancer; 2003 Nov; 98(10):2232-44. PubMed ID: 14601094
[TBL] [Abstract][Full Text] [Related]
8. [Intracranial ependymomas. Study of 81 cases and comparison with the literature].
Namer IJ; Pamir MN; Benli K; Erbengi A
Neurochirurgie; 1984; 30(3):153-8. PubMed ID: 6462320
[TBL] [Abstract][Full Text] [Related]
9. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
10. Extradural ependymal tumor with myxopapillary and ependymoblastic differentiation in a case of Schinzel-Giedion syndrome.
Beschorner R; Wehrmann M; Ernemann U; Bonin M; Horber V; Oehl-Jaschkowitz B; Meyermann R; Dufke A
Acta Neuropathol; 2007 Mar; 113(3):339-46. PubMed ID: 17165030
[TBL] [Abstract][Full Text] [Related]
11. Ependymoma: internal correlations among pathological signs: the anaplastic variant.
Schiffer D; Chiò A; Cravioto H; Giordana MT; Migheli A; Soffietti R; Vigliani MC
Neurosurgery; 1991 Aug; 29(2):206-10. PubMed ID: 1886658
[TBL] [Abstract][Full Text] [Related]
12. [Brain tumors in infants and children--factors affecting prognosis. (Part 1) Ependymoma (author's transl)].
Oi S; Raimondi AJ
No Shinkei Geka; 1980 Nov; 8(11):1049-55. PubMed ID: 7453936
[TBL] [Abstract][Full Text] [Related]
13. Ependymomas: a clinical and pathologic study. Part II. Survival features.
Ilgren EB; Stiller CA; Hughes JT; Silberman D; Steckel N; Kaye A
Clin Neuropathol; 1984; 3(3):122-7. PubMed ID: 6565537
[TBL] [Abstract][Full Text] [Related]
14. Ovarian ependymomas of extra-axial type or central immunophenotypes.
Stolnicu S; Furtado A; Sanches A; Nicolae A; Preda O; Hincu M; Nogales FF
Hum Pathol; 2011 Mar; 42(3):403-8. PubMed ID: 21195452
[TBL] [Abstract][Full Text] [Related]
15. Both location and age predict survival in ependymoma: a SEER study.
McGuire CS; Sainani KL; Fisher PG
Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.
Metellus P; Figarella-Branger D; Guyotat J; Barrie M; Giorgi R; Jouvet A; Chinot O;
Cancer; 2008 Jul; 113(1):175-85. PubMed ID: 18470910
[TBL] [Abstract][Full Text] [Related]
17. The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature.
Fassett DR; Pingree J; Kestle JR
J Neurosurg; 2005 Jan; 102(1 Suppl):59-64. PubMed ID: 16206735
[TBL] [Abstract][Full Text] [Related]
18. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and management of intracranial ependymomas.
Papadopoulos DP; Giri S; Evans RG
Anticancer Res; 1990; 10(3):689-92. PubMed ID: 2369084
[TBL] [Abstract][Full Text] [Related]
20. Primitive intracranial ependymomas. Salah-Azaîz institute experience.
Ben Ammar CN; Kochbati L; Frikha H; Gargouri W; Benna F; Besbes M; Ben Abdallah M; Ben Attia R; Maalej M
Cancer Radiother; 2004 Apr; 8(2):75-80. PubMed ID: 15063874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
